Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
When it comes to treating hemorrhoids surgically, excisional hemorrhoidectomy (EH) leads the pack for long-term symptom relief — but laser hemorrhoidoplasty (LHP) isn't far behind. A 5-year randomized trial found EH had the lowest recurrence rate, while LHP delivered comparable effectiveness with significantly less postoperative pain and a faster recovery. Sutured mucopexy lagged behind both.
A 5-year randomized controlled trial has put three hemorrhoid surgeries head-to-head — and excisional hemorrhoidectomy (EH) came out on top for keeping symptoms at bay. But laser hemorrhoidoplasty (LHP) held its own, offering nearly equivalent long-term outcomes with a notably shorter and less painful recovery. Sutured mucopexy (MP) trailed both in most measures.
The prospective, double-blind trial enrolled 121 patients with symptomatic second- or third-degree hemorrhoids who hadn't responded to conservative treatments. After 5 years, 102 patients completed follow-up across all three groups.
By the Numbers:
Why it matters: For clinicians counseling patients on hemorrhoid surgery, this data reinforces EH as the gold standard for durability — but LHP emerges as a strong alternative for patients who prioritize a smoother recovery, with only a modest trade-off in recurrence risk.
